David H. Kim

Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms

David Malkin, Frederick P. Li, Louise C. Strong et al. · Science · 1990 · 3.8K citations

Life Sciences, Genetics, Oncology +17

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

Medicine, Endocrinology, Pharmacology +14

CT Colonography versus Colonoscopy for the Detection of Advanced Neoplasia

David H. Kim, Perry J. Pickhardt, Andrew Taylor et al. · New England Journal of Medicine · 2007 · 706 citations

Medicine, Oncology, Radiology +17

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text

Medicine, Endocrinology, Nephrology +15

Spondylolysis and Spondylolisthesis

Leonid Kalichman, David H. Kim, Ling Li et al. · Spine · 2009 · 391 citations · Full text

Medicine, Orthopaedic Surgery, Radiology +17